The deal will expand Elevance’s capabilities to provide affordable specialty medication services for patients with chronic and complex illnesses. Credit: rafapress / Shutterstock.

US-based health company Elevance Health has completed the deal to buy Paragon Healthcare, a provider of infusible and injectable therapies.  

Headquartered in Plano, Texas, US, Paragon Healthcare was founded in 2022 and operates a network of ambulatory infusion centres, home infusion and other specialty pharmacies.  

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

At present, the company has over 40 ambulatory infusion centres and caters to more than 35,000 patients across eight US states, namely Colorado, Alabama, Florida, Georgia, Texas, Missouri, Oklahoma, and Tennessee.  

The acquisition, whose financial details remain undisclosed, was agreed upon in January 2024.  

It is set to expand Elevance Health’s capabilities to provide affordable and easy access to speciality medication services, particularly for patients with chronic and complex illnesses.  

See Also:

Paragon Healthcare will now be integrated into CarelonRx, the pharmacy services segment of Carelon, which is Elevance Health’s health services division. 

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In addition, Elevance Health looks to expand Paragon Healthcare’s geographic reach and operations.  

This expansion is expected to strengthen the company’s therapeutic coverage and ensure that members gain access to medications on time. 

Elevance Health executive vice president and Carelon president Pete Haytaian said: “We are excited to welcome Paragon Healthcare – a leading provider of infusion services – to our Elevance Health family. 

“Together, we have the opportunity to provide members with greater choice on where they receive their infused medications, which will ultimately remove barriers to care, increase medication adherence, lower costs of care, and better support members’ whole health.” 

Elevance Health serves around 117 million people via its portfolio of medical, digital, pharmacy, behavioural, clinical, and complex care solutions.